Cite
Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection.
MLA
Li, Hongtao, et al. “Methyl Rosmarinate Is an Allosteric Inhibitor of SARS-CoV-2 3 CL Protease as a Potential Candidate against SARS-Cov-2 Infection.” Antiviral Research, vol. 224, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.antiviral.2024.105841.
APA
Li, H., Sun, M., Lei, F., Liu, J., Chen, X., Li, Y., Wang, Y., Lu, J., Yu, D., Gao, Y., Xu, J., Chen, H., Li, M., Yi, Z., He, X., & Chen, L. (2024). Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection. Antiviral Research, 224, N.PAG. https://doi.org/10.1016/j.antiviral.2024.105841
Chicago
Li, Hongtao, Meng Sun, Fuzhi Lei, Jinfeng Liu, Xixiang Chen, Yaqi Li, Ying Wang, et al. 2024. “Methyl Rosmarinate Is an Allosteric Inhibitor of SARS-CoV-2 3 CL Protease as a Potential Candidate against SARS-Cov-2 Infection.” Antiviral Research 224 (April): N.PAG. doi:10.1016/j.antiviral.2024.105841.